PROSPER: a phase III trial of lecithinized superoxide dismutase to prevent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer
- DOI
- 10.1016/j.esmogo.2026.100353
- Published
- 2026-09
- Container
- ESMO Gastrointestinal Oncology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmogo.2026.100353,
title = {PROSPER: a phase III trial of lecithinized superoxide dismutase to prevent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer},
author = {K. Yamazaki and T. Kato and T. Yamada and K. Ogihara and T. Ishikawa and N. Ishizuka and T. Yoshino and K. Yamaguchi and T. Mizushima},
year = {2026},
journal = {ESMO Gastrointestinal Oncology},
doi = {10.1016/j.esmogo.2026.100353},
url = {https://doi.org/10.1016/j.esmogo.2026.100353}
}RIS
TY - JOUR TI - PROSPER: a phase III trial of lecithinized superoxide dismutase to prevent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer AU - K. Yamazaki AU - T. Kato AU - T. Yamada AU - K. Ogihara AU - T. Ishikawa AU - N. Ishizuka AU - T. Yoshino AU - K. Yamaguchi AU - T. Mizushima PY - 2026 JO - ESMO Gastrointestinal Oncology DO - 10.1016/j.esmogo.2026.100353 UR - https://doi.org/10.1016/j.esmogo.2026.100353 ER -
APA
Yamazaki, K., Kato, T., Yamada, T., Ogihara, K., Ishikawa, T., Ishizuka, N., Yoshino, T., Yamaguchi, K., & Mizushima, T. (2026). PROSPER: a phase III trial of lecithinized superoxide dismutase to prevent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer. ESMO Gastrointestinal Oncology. https://doi.org/10.1016/j.esmogo.2026.100353
Source records
- crossref · retrieved 2026-09-25T22:47:34.921Z